Skip to main content
Alvotech (ALVO)
NASDAQ: ALVO · IEX Real-Time Price · USD
11.59
+0.30 (2.66%)
Jul 26, 2024, 4:30 PM EDT - Market closed

Alvotech Revenue

Alvotech had revenue of $36.89M in the quarter ending March 31, 2024, with 132.29% growth. This brings the company's revenue in the last twelve months to $114.39M, up 14.27% year-over-year. In the year 2023, Alvotech had annual revenue of $93.38M with 9.84% growth.

Revenue (ttm)
$114.39M
Revenue Growth
+14.27%
P/S Ratio
30.88
Revenue / Employee
$111,494
Employees
1,026
Market Cap
3.50B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202393.38M8.37M9.84%
Dec 31, 202285.02M45.33M114.23%
Dec 31, 202139.68M-29.77M-42.86%
Dec 31, 202069.45M-13.23M-16.00%
Dec 31, 201982.68M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Prestige Consumer Healthcare 1.13B
Neogen 929.24M
GoodRx Holdings 764.16M
Corcept Therapeutics 523.53M
Axonics 387.14M
Denali Therapeutics 295.39M
PROCEPT BioRobotics 156.33M
Arrowhead Pharmaceuticals 35.47M
Revenue Rankings

ALVO News

More News